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Abstract 43 
Background/objectives: Weight loss maintenance is challenging, and few succeed in the 44 
long term. This study aimed to explain how appetite-related hormones, adaptive 45 
thermogenesis, perceived hunger and stress influence weight loss maintenance.  46 
Subjects/methods: Fifteen adult women (age, 46.3±9.5 years; BMI, 39.4±4.3 kg/m2) 47 
participated in a 24-month intervention, which included 3-5 months total diet replacement 48 
(825–853 kcal/d). Body weight and composition (Magnetic Resonance Imaging), resting 49 
metabolic rate (indirect calorimetry), and fasting plasma concentration of leptin, ghrelin, 50 
glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and growth differentiation factor 15 51 
(GDF-15) were measured at baseline and after weight loss, around 6 months. Perceptions 52 
relating to weight loss maintenance were explored using qualitative interviews. 53 
Results: Mean (SD) changes in body weight (-13.8±6.3kg) and total adipose tissue (-11.5±4.9 54 
kg) were significant (P<0.001). Weight loss was associated with a significant reduction in 55 
resting metabolic rate (-291±226kcal/day, P<0.001) and adaptive thermogenesis (-56 
150±162kcal/day, P=0.003), reduction in leptin (P<0.001) and GLP-1 (P=0.015), an increase 57 
in ghrelin (P<0.001), and no changes in PYY and GDF-15. Weight regain between 6 and 24 58 
months (6.1±6.3 kg, P<0.05) was correlated positively with change in GLP-1 (r= 0.5, P=0.037) 59 
and negatively with GLP-1 at baseline (r= -0.7, P=0.003) and after weight loss (r= -0.7, 60 
P=0.005). Participants did not report increased hunger after weight loss, and stress-61 
related/emotional eating was perceived as the main reason for regain.  62 
Conclusions: Weight regain is more likely with lower fasting GLP-1 and greater reduction in 63 
GLP-1 after weight loss, but psychological aspects of eating behaviour appear as important 64 
in attenuating weight loss maintenance.  65 
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The study was registered at clinicaltrials.gov as NCT02340793. 69 
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Introduction 71 
Overweight and obesity affects more than two-thirds of adults in the UK, >2 billion people 72 
worldwide (1) and is an important risk factor for several causes of premature morbidity and 73 
mortality (2). The probability of achieving a healthy body weight once obesity becomes 74 
established is low (3) but modest weight loss (5-10%) can significantly improve health (4) 75 
and more substantial losses (>10-15%) can make dramatic improvements, such as remission 76 
of type 2 diabetes (5). However, few people are able to maintain diet-induced weight losses 77 
(4, 6) in the face of physiological, environmental and behavioural factors (7) that combine to 78 
draw them back to their initial weight. It is widely believed that efforts to reduce energy 79 
intake and lose weight are resisted through interacting pathways, resulting in an increased 80 
drive to eat and a reduction in energy expenditure (8), mechanisms which probably evolved 81 
to protect against starvation (9).  82 
The homeostatic control of appetite is largely controlled by the hypothalamic arcuate 83 
nucleus which integrates peripheral signals coming from adipose tissue (e.g. leptin) and 84 
gastrointestinal peptides (e.g. GLP-1, PYY, ghrelin) (10). Compensatory changes to pathways 85 
regulating appetite following diet-induced weight loss are thought to favour increased 86 
energy intake (11), though whether hormonal adaptations persist in the long-term is 87 
unclear, and contradictory findings have been reported (11, 12). Adaptive thermogenesis, 88 
generally assessed as the reduction in energy expenditure beyond what can be explained by 89 
changes in body size and composition, may further undermine weight loss maintenance (13, 90 
14). Three models have been proposed to explain this phenomenon (15), but whilst energy 91 
expenditure adaptations may influence maintenance success, it is changes in appetite 92 
regulation that are considered the main driver of weight regain (16). The extent to which 93 
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these mechanisms are causal remains largely speculative since evidence linking both 94 
hormonal (11, 17-19) and energy expenditure (20) adaptations with weight regain is lacking. 95 
Eating behaviour is strongly influenced by environmental determinants (21), and disconnect 96 
between expected actions of GLP-1 and PYY and subjective measures of appetite and energy 97 
intake (22, 23) suggest that humans may be more responsive to external stimuli than 98 
internal biological cues (24). A recent systematic review of theoretical explanations 99 
identified five main themes as important for behaviour change maintenance: motivation 100 
(including enjoyment and identity); self-regulation (including skills and coping); habit (to 101 
create and break); cognitive resources (including limits due to stress, tiredness); and 102 
environmental and social influences (including support) (25). Most studies have been 103 
directed at either physiological, endocrine, or psychological determinants of weight control 104 
(26). The present study was designed to integrate the contribution of these components 105 
and investigate their role in regain after weight loss using a low-calorie diet intervention in 106 
women with obesity. 107 
Subjects and methods  108 
Participants 109 
Weight-stable (≤5kg weight loss in previous 6 months) females aged 18-65 years with body 110 
mass index (BMI) 30-45 kg/m2 were recruited by posters advertising the study in a local 111 
hospital.  Main exclusion criteria were clinically significant illness (e.g. heart disease/cancer), 112 
severe depression, taking medications known to affect body weight, diagnosed eating 113 
disorder or history of substance abuse. The study was approved by the West of Scotland 114 
Research Ethics Committee (reference number: 14/WS/1164) and NHS Greater Glasgow & 115 
Clyde Research and Development department and conducted in accordance with the 116 
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Declaration of Helsinki. All participants provided written informed consent. The study was 117 
registered prospectively with the Clinical Trials registry, identifier number: NCT02340793. 118 
Study design 119 
This was a single arm weight-loss and maintenance intervention study, which measured 120 
body weight before the weight management programme, at the point of approximate 121 
maximal body weight loss (around 6 months), and at 24 months to coincide with the end of 122 
the weight loss maintenance phase. Body composition and resting metabolic rate were 123 
measured and fasting blood samples collected at baseline and 6 months. In addition, a 124 
sample of participants (n=11) completed semi-structured qualitative interviews, at baseline 125 
and programme end, and at intervals throughout the programme.   126 
Weight management programme  127 
Participants were asked to follow the Counterweight Plus weight management programme 128 
(27), which starts with an intensive period of low calorie diet. The intervention was 129 
delivered by a registered dietitian over a 24-month period and included three phases. Phase 130 
1: ‘Total Diet Replacement’ to initiate weight loss (3-5 months shakes/soups; 825-131 
853kcals/day; 59% carbohydrate, 13% fat, 26% protein, 2% fibre), Phase 2: ‘Food 132 
Reintroduction’ (1-2 months stepped increase in calorie intake to reach stable body weight) 133 
and Phase 3: ‘Weight Loss Maintenance’ which offered longer term support, optional meal 134 
replacements and relapse management strategies (approximately 18 months). Study visits 135 
of 20-40 minutes were fortnightly during Phase 1 and Phase 2, and monthly during Phase 3.  136 
 137 
 138 
Role of appetite hormones, hunger and stress in weight regain 
 
 7 
Anthropometry and body composition  139 
Body weight was measured to the nearest 0.1 kg by calibrated scales. Whole-body Magnetic 140 
Resonance Imaging (MRI) was used to assess volumes of total adipose tissue (TAT) and 141 
skeletal muscle (Philips Ingenia 1.5T scanner; Best, Netherlands). Each participant was 142 
scanned twice, before and after weight loss. Images were obtained from elbow to ankle 143 
using a transversal T1-weighted protocol (TR/TE = 416/6ms, matrix size = 480x480, FoV = 144 
558x558mm2 voxel size = 1.15x1.15x5mm3), using the scanner body coil. Due to higher BMI 145 
of participants, whole body coverage was achieved by scanning the maximum FoV available 146 
and participants were first scanned with one arm up, then the second arm was scanned by 147 
itself. Total scanning time was 45-60 minutes. Volumes of TAT were segmented by using a 148 
combination of manual and threshold MR signal segmentation with the aid of the extended 149 
MR workspace Philips software. All images were segmented by an MRI physicist (RLG) with 150 
14 years MRI experience. Total muscle and adipose volumes were converted from cm3 to 151 
litres, and then to mass using the assumed densities of 1.04kg/l and 0.92kg/l, respectively. 152 
Small sites of adipose tissue below the voxel size in organs and other tissues were below 153 
detection limits, due to partial volume effects, and classified as non-adipose tissue.  154 
Resting metabolic rate 155 
RMR was measured following a 12-hour overnight fast by means of a computerised open-156 
circuit ventilated hood system (Oxycon Pro, Jaeger GmbH, Hoechberg, Germany) in line with 157 
standard procedures (28). Participants were free-living but asked to avoid exercise for the 158 
24 hours prior to testing and travelled to the human nutrition metabolic laboratory by car or 159 
taxi. Participants rested in a supine position for a period of 20 minutes prior to RMR 160 
measurement, which took place in a thermoneutral environment. Each measurement 161 
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followed a 20-minute protocol, with rate of oxygen consumption (V̇O2) and carbon dioxide 162 
production (V̇CO2) being recorded every 30 seconds. To ensure steady state conditions were 163 
achieved, data obtained during the first 5 minutes were discarded and V̇O2 and V̇CO2 164 
measured during the following 15 minute period were required to have a coefficient of 165 
variation ≤10% to be considered for the calculation of resting metabolic rate using standard 166 
indirect calorimetry equations (29). The accuracy of the Oxycon Pro system was validated by 167 
alcohol-burning tests (30) which were included in the Standard Operating Procedure of the 168 
system and conducted weekly with an averaged coefficient of variation of 1.6%. Volume and 169 
gas calibrations were performed prior to each measurement and were accepted if 170 
differences were ≤±1%.). The validity of the Oxycon Pro system for RMR measurement was 171 
previously determined by our group by comparing resting oxygen uptake (V̇O2) and carbon 172 
dioxide production (V̇CO2) measured by the Oxycon Pro system and the Douglas bag 173 
method.  Bland and Altman analyses demonstrated minimal low bias and narrow limits of 174 
agreement. In addition, test-retest reliability of Oxycon Pro measurements during rest in 175 
normal body weight healthy individuals was reported to be high (22). 176 
Adaptive Thermogenesis 177 
Baseline data from all 15 participants were used to generate a sample-specific linear 178 
regression equation to predict RMR as a function of TAT (kg), skeletal muscle mass (SMM) 179 
residuals (kg) and age (R2= 0.78):  180 
RMR (kcal/day) = 1449.1 + 12.2*TAT (kg) + 51.8*SMM residuals (kg) -8.7*Age (years). 181 
The individual predicted RMR of each participant was calculated using this equation along 182 
with the corresponding TAT (kg), SMM residuals (kg) and age measured after weight loss, 183 
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and adaptive thermogenesis was calculated as measured-minus-predicted RMR and 184 
considered present if values were different from zero.  185 
Blood collection and analysis 186 
Venous blood samples were collected into EDTA vacuette tubes (Greiner Bio-One, 187 
Kremsmünster, Austria). After centrifugation (4C, 3000 rpm for 15 min) the plasma was 188 
collected and frozen at -80C until analysis. ELISA kits were used to measure fasting 189 
concentrations of plasma leptin, PYY, total ghrelin, total GLP-1 (all Merck Millipore, UK Ltd) 190 
and GDF-15 (R&D Systems, UK). All assays were performed according to the manufacturers’ 191 
instructions and quality controls were within pre-specified limits. Coefficients of variation 192 
(CV) were ≤8% for all measures: leptin (4.2%), GDF-15 (2.9%), PYY (6.5%), total ghrelin 193 
(2.3%), and total GLP-1 (8.0%). 194 
Statistical analysis   195 
Data are presented as mean ± standard deviation (SD). Data normality was assessed using 196 
the Shapiro-Wilk test, and visual inspection of the accompanying histograms, normal Q-Q 197 
plots and box plots. Changes in metabolic and body composition measures were analysed 198 
by paired t-test or non-parametric Wilcoxen signed rank test. Spearman’s correlation 199 
coefficient was used to test associations between adaptive thermogenesis, leptin, PYY, 200 
ghrelin, GLP-1, GDF-15 and weight change between 6 and 24-months. All statistical analyses 201 
were conducted using SPSS version 24.0 (Armonk, NY: IBM Corp). Statistical significance was 202 
set at P<0.05. There were no prior data from which to do a power calculation, but the 203 
results will permit a retrospective power estimate. 204 
 205 
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Qualitative interviews  206 
Semi-structured qualitative interviews were conducted longitudinally and informed by a 207 
topic guide (additional information in supplementary appendix) which was developed in line 208 
with a theoretical model outlining psychological determinants of maintenance (25). 209 
Discussion was prompted around five key themes: maintenance motives, psychological 210 
resources, self-regulation, habits and social/environmental influences. The current study 211 
investigated difficulties with adherence during weight loss maintenance, specifically relating 212 
to how perceived hunger/appetite and stress influence eating behaviour. All interviews 213 
were conducted by one researcher (GT) by telephone, audio-recorded and transcribed. 214 
Interviews were scheduled at baseline and programme end, up to monthly during Phase 1 215 
and 2, and 3-monthly during Phase 3. Interview frequency was reduced if discussions 216 
became repetitive, and discontinued when data saturation was reached on the main 217 
analytical themes.  218 
Qualitative data analysis 219 
Coding’s were made in NVivo12 using the framework method (31), guided by the underlying 220 
maintenance model (25). Analysis used a four-step process to understand the link between 221 
appetite-related hormones, perceived hunger/appetite and weight loss maintenance. Step 1 222 
involved data familiarisation, where each transcript was read, and high-level descriptors for 223 
each participant were constructed. Step 2 was coding each transcript. Step 3 involved 224 
specifically examining hunger/appetite as a motivator for eating, and Step 4 was identifying 225 
other factors perceived by participants to influence eating behaviour during weight loss 226 
maintenance, specifically relating to stress and difficulties with adherence to understand 227 
their role in weight regain.  228 
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Results 229 
Participants 230 
Figure 1 shows study format, enrolment and drop-out. Overall, 22 women met the inclusion 231 
criteria and started the programme. Seven withdrew during Phase 1 (Total Diet 232 
Replacement) and did not attend follow up measurements. Therefore, data from 15 233 
participants (age, 46.3 ± 9.5 years, BMI, 39.4 ± 4.3 kg/m2) are presented in this manuscript. 234 
Venous access could not be obtained for one individual, thus hormone data are based on 14 235 
participants. Characteristics of all participants are presented in Table 1.   236 
Eleven of the study participants (aged 44.9 ± 9.8 years; BMI 40.3 ± 4.0 kg/m2) took part in 237 
qualitative interviews, and 9/11 completed the 24-month weight management programme. 238 
One dropped out due to work commitments and the other could not tolerate the dietary 239 
intervention in Phase 1, but both completed exit interviews during the follow-up period. On 240 
average, interviews lasted 40 minutes (range: 10-100 minutes), and participants completed 241 
a median of 6 (range: 4-8) interviews. Mean weight losses at 6 months (14.7 ± 7.1 kg) and at 242 
24-months (8.5 ± 8.5 kg) for those who completed the qualitative studies (Table 2) were 243 
similar to the overall cohort.  244 
Body weight and body composition  245 
Individual changes in body weight are displayed in Figure 2, and as a group in Table 1. At 6 246 
months, participants lost 13.8 ± 6.3 kg, equivalent to 13.5 ± 5.5% of total body weight 247 
(P<0.001). Reductions in TAT (-11.5 ± 4.9 kg) were significant (P<0.001) and change in 248 
skeletal muscle mass was small and not significant (-0.40 ± 0.88 kg; P=0.012) (Table 1). 249 
Between 6 and 24-months body weight increased by 6.1 ± 6.3 kg (P=0.002) but remained 7.7 250 
± 9.7 kg below baseline (P=0.009). A retrospective power calculation using the present data 251 
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confirms that this study, which found an effect size of -11.5 kg in TAT, was sufficiently 252 
powered to detect or exclude an effect size above 3.5 kg for change in TAT, with SD=4.9 kg 253 
and n=15, at 80% power. 254 
Appetite-related hormones 255 
Weight loss at 6 months was associated with significant reductions in fasting plasma leptin 256 
and GLP-1 concentrations, an increase in ghrelin, but no changes in GDF-15 or PYY (Table 1), 257 
and large individual variability was observed (Figure 3). Body weight regain from 6 to 24 258 
months was positively correlated with changes in fasting GLP-1 concentration (r= 0.5, 259 
P=0.037) and negatively with GLP-1 concentration, measured before dietary intervention (r= 260 
-0.7, P=0.003) and at the point of maximal body weight loss (r= -0.7, P=0.005) (Figure 4). 261 
There were no significant correlations between body weight changes between 6 and 24-262 
months and fasting concentrations of leptin, PYY, ghrelin, GDF-15, or changes in their fasting 263 
concentrations. The decision to use fasting measurements was influenced by evidence from 264 
our other ongoing study which found significant correlations (r=0.8, P=0.001) between 265 
fasting and time averaged postprandial concentrations of GLP-1 and PYY measured over 7-266 
hours of the postprandial state in overweight women. 267 
Resting metabolic rate and adaptive thermogenesis  268 
RMR measured at 6 months 1497 ± 225 kcals/d was significantly (P<0.001) lower than at 269 
baseline (1788 ± 349 kcal/d) and the difference between measured and predicted RMR was 270 
also significant (-150 ± 162 kcals/d, P=0.003), with large inter-individual variability in 271 
adaptive thermogenesis evident. No significant correlation was found between weight 272 
change at 24-months and change in RMR (r = -0.39, P=0.89) or adaptive thermogenesis (r= 273 
0.19, P=0.51). Duplicate RMR measurements were taken in 7 weight-stable (±1.0 kg) 274 
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individuals to quantify biological variation and random error, and coefficient of variation 275 
was 2.3%. 276 
Appetite and hunger 277 
Relevant quotes relating to psychological aspects (perceived hunger/appetite and 278 
emotions/stress) during weight loss maintenance are displayed in Table 2 along with weight 279 
loss outcomes. During Total Diet Replacement (Phase 1), hunger was reported by a few 280 
participants, though it was generally tolerable and ways of coping were found. The majority 281 
reported not experiencing increased hunger, which was a surprise to some participants 282 
given the nature of the dietary regime (“I was surprised at how easy I found it […] I expected 283 
to be hungry and I wasn’t…”, P-10, 1-month). As hunger and satiety promoting hormones 284 
are assumed to be causal factors in undermining weight loss maintenance (32) participants 285 
may be expected to report increased appetite and hunger as drivers of eating behaviour, 286 
after weight loss. Despite the physiological findings outlined above (e.g. significant changes 287 
in GLP-1, ghrelin and leptin), increased hunger was not reported by most participants during 288 
weight loss maintenance (Table 2). One participant who regained 10kg described difficulties 289 
with hunger during weight loss maintenance. They had the lowest secretion of ghrelin 290 
(hunger biomarker) within the cohort, both before (230 pg/ml) and after (338 pg/ml) weight 291 
loss, but also experienced significantly stressful life events, and discussed hunger alongside 292 
these difficulties (“…it had been a bit of a fraught week anyway and […] if there’s something 293 
going on and you’re hungry […] you think well you can’t always get full control of everything 294 
else but you can stop yourself being hungry…”, P-7, 24-months). 295 
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Self-regulation of emotions and eating behaviours  296 
Most participants reported eating as a way of dealing with general life stressors and periods 297 
of low mood. Episodes of family and work-related stress were common, and prompted 298 
participants to seek pleasure in energy dense ‘comfort foods’. Those maintaining the most 299 
weight loss at 24-months tended to report a greater ability to tolerate stress after weight 300 
loss, and used physical activity to manage negative emotions. Those regaining more weight 301 
tended to be less consistent in dealing with emotional difficulties, and were more likely to 302 
be worn down by ongoing life stressors and food was used as a strategy to deal with and 303 
distract from unpleasant feelings.  304 
Discussion  305 
This study found that weight regain at 24-months following an average 13.5% body weight 306 
loss was positively associated with change in fasting GLP-1 concentration and negatively 307 
with fasting GLP-1 measured before and at maximal weight loss. Qualitative interviews 308 
suggested that weight loss maintenance was compromised by lower self-regulation of 309 
eating behaviour, which was most commonly a consequence of perceived stress and 310 
emotional difficulties. This study suggests that individuals with higher fasting plasma GLP-1 311 
concentrations and lower reduction in GLP-1 during diet-induced weight loss, and an ability 312 
to manage emotional difficulties without compensatory eating can be expected to be more 313 
successful at weight loss maintenance.  314 
GLP-1 concentrations were reduced following weight loss, which is in line with other studies 315 
(11, 23, 33-35). The role of GLP-1 in body weight-regulation is well documented but finding 316 
that inter-individual differences in weight loss maintenance were related to fasting GLP-1 is 317 
novel and requires further investigation. These data suggest that individuals with lower 318 
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fasting GLP-1 might be more vulnerable to weight regain and require additional help to 319 
maintain weight losses. Our findings are consistent with evidence from bariatric surgery 320 
studies, reporting that poorer long-term weight loss maintenance outcomes are associated 321 
with attenuated GLP-1 response (36). GLP-1 infusion enhances satiety and reduces energy 322 
intake (37) and brain imaging studies have demonstrated that higher GLP-1 concentration 323 
diminishes the reward value of food (38, 39). GLP-1 analogue therapy is associated with 324 
improved weight loss maintenance (40) and identifying individuals with low concentrations 325 
of GLP-1 may help to establish who is likely to respond well or poorly to a weight loss 326 
intervention (41) and facilitate targeted treatments, with non-pharmalogical approaches to 327 
increase endogenous GLP-1 now under study (42). Our findings need to be confirmed using 328 
a randomised controlled trial design. A retrospective power analysis using the present data 329 
can now provide the basis for likely effect sizes and a sample size estimation. For example, 330 
with GLP-1 as the primary outcome in a future study, our data indicate a mean effect size of 331 
13.0 pmol/l with SD 17.3, from a mean weight loss 13.8kg. If the minimum clinically relevant 332 
effect size is 10.0 pmol/l, then these data would demand a sample size of 94, to provide 333 
80% power in a two-arm randomised trial (47 in each arm) to detect or exclude this effect 334 
size with p<0.05. 335 
We observed large inter-individual variability across all variables, which again underlines the 336 
challenge of identifying factors which consistently associate with weight loss 337 
maintenance/regain (43). Weight loss reduced plasma leptin and increased total ghrelin 338 
concentrations, which seems to a large extent to reflect changes in adiposity (44-46). 339 
Although reductions in PYY are usually expected following major (11, 18) and modest weight 340 
loss (47, 48), we found no change, which has also been reported elsewhere (12, 49). Weight 341 
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regain was not related to baseline concentrations of leptin, ghrelin, PYY or GDF-15, or 342 
intervention-induced changes in these hormones, which supports previous studies (11, 17, 343 
18, 50).  344 
As expected, weight loss led to a significant fall in RMR. The mean reduction in RMR below 345 
values predicted from body weight and composition was also significant and averaged -150 346 
kcals/day but did not associate with weight regain at 24-months. Thus, these data do not 347 
produce strong evidence to support the concept of adaptive thermogenesis, to explain 348 
difficulty in maintaining weight loss, and similar findings have been published elsewhere 349 
(20). The presence and possible magnitude of adaptive thermogenesis has been 350 
inconsistently documented in human studies and accurately determining its existence in 351 
free-living individuals remains difficult (51, 52). The mean reduction in SMM of only 0.4kg 352 
muscle loss was unexpected, and lower than has been reported in more detailed studies 353 
(53) and may have been influenced by lifestyle habits of participants during the 354 
intervention.  355 
Whilst physiological adaptations have dominated discussions regarding body weight regain, 356 
the mechanisms through which these changes influence behaviour and energy balance are 357 
not well understood, and this explanation overlooks the importance of psychological factors 358 
in determining treatment outcomes (41). Within this study, hunger was not perceived to be 359 
relevant to participants’ weight loss maintenance, despite the significant increase in ghrelin. 360 
Other researchers have reported increases in perceived hunger after weight loss (11, 18, 361 
50). The difference in the findings may relate to methodological differences, to the specific 362 
dietary advice, and to timing of appetite data collection. We evaluated hunger by qualitative 363 
interview, with questions phrased to elicit reflections over a period of time. Other studies 364 
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have used appetite rating scales at set timepoints to coincide with blood collection for 365 
appetite hormone measurements (11, 18, 50). Disconnect between subjective appetite 366 
ratings and concentrations of appetite-related hormones is not unusual (22, 23), so the 367 
degree to which ‘appetite hormones’ reflect perceived hunger, or memory of hunger, is 368 
uncertain. Self-reporting is the only possible way to estimate appetite, so its reliability can 369 
never be verified (54). Whether changes in appetite-related hormones are part of a 370 
compensatory response contributing to weight regain, or simply a consequence of weight 371 
loss still needs to be fully understood (10). Our findings would suggest that any effects on 372 
hunger/appetite occur outside of individuals’ conscious awareness. 373 
Greater integration of knowledge across disciplines is required to foster deeper 374 
understanding of issues relating to weight loss maintenance (26). In this study we combined 375 
quantitative and qualitative approaches as an innovative way of addressing some of the 376 
most relevant factors considered to contribute to weight regain. It was notable that 377 
participants perceived self-regulation difficulties in response to stress and negative mood 378 
states as the key factor promoting eating and weight regain, rather than any changes in 379 
appetite. Clinicians working in weight management will be familiar with this narrative and 380 
the method used to collect qualitative accounts within this study provides robust 381 
documentation of this perspective. Stress interferes with emotion regulation, and eating 382 
may occur partly because self-control is weakened, and because it helps to reduce stress 383 
(55). Participants reported that dietary lapses were most likely under family and work 384 
stress, and this is consistent with systematic review findings which reported that adopting 385 
healthier eating habits can generate psychological ‘tension’, where new behaviour patterns 386 
fail to meet the need for emotion regulation previously served by obesogenic behaviours 387 
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(56). Stress can undermine motivation and deplete self-regulatory capacity, which may be a 388 
limited resource (57), and it is well established that women are likelier to exhibit stress-389 
eating behaviour than men (58). In an online survey of 2000 men and women following their 390 
most recent weight loss attempt, comfort eating for emotional reasons, including stress, 391 
was the most common explanation cited for regain (59). Our findings would suggest that 392 
emotional and behavioural factors are at least as important in influencing eating behaviour 393 
as hormonal factors. Thus, developing effective coping skills to address stress-related 394 
‘comfort’ eating should be a central component of weight loss maintenance interventions.   395 
This study has several limitations. We obtained only fasting appetite hormone 396 
concentrations though more pertinent information for some biomarkers occurs 397 
postprandially. However, this places greater burden on participants and it is now recognised 398 
that predicting treatment response from fasting measurements strikes an appropriate 399 
balance between informational value and feasibility (60). We investigated GLP-1, PYY, 400 
ghrelin, GDF-15 and leptin but energy balance in the weight reduced state may also be 401 
influenced by other gut appetite hormones (10) and endocrine signals from 402 
triiodothyronine, and sympathetic nervous system activity (61). Investigation of adaptive 403 
thermogenesis relied on RMR: we did not investigate non-resting energy expenditure, which 404 
is also affected by body weight (62). There is always concern about biological variation 405 
through subtle behavioural and dietary changes, and random error on RMR measurement, 406 
to establish whether apparent changes in RMR are real. To provide a stable RMR, it is 407 
necessary, but difficult, to establish precise energy-balance before and after weight loss. We 408 
made efforts to standardise diets and behaviours during the 24-hours prior to RMR 409 
measurements, and the duplicate measurements in weight stable individuals were 410 
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reassuring, with low coefficient of variation. We are therefore confident that major random 411 
error has been avoided. The study benefitted from rigorous body composition assessment 412 
by whole-body MRI, which was the basis for calculating adaptive thermogenesis, whereas 413 
other studies have used weaker indirect estimates of body composition. However, methods 414 
normalising RMR for TAT and SMM (or fat mass/fat free mass) using regression analysis 415 
involve uncertainty, and this is a statistical rather than physiological approach and 416 
potentially prone to errors (63). This study may have been strengthened by undertaking a 417 
very detailed assessment of FFM composition, by quantifying volumes from MRI and 418 
estimating masses of liver, heart, kidneys and brain, and then calculating RMR (and adaptive 419 
thermogenesis) using tissue-specific metabolic rates (53, 61). This interesting approach 420 
relies on estimates of tissue-specific metabolic rate, usually based on blood flow 421 
measurements under fixed experimental conditions which would not be exactly replicated 422 
by our participants, and organ-specific metabolic rates are likely to differ before and after 423 
major weight loss in the present study. Data are not available for all metabolically active 424 
tissues within the lean body mass (e.g. skin, bowel, pancreas and endocrine organs) and 425 
some relatively small tissues can exhibit wide fluctuations in metabolic rate (e.g. brown 426 
adipose tissue). This type of analysis may thus not be able to provide more reliable 427 
estimates of whole-body metabolic rate for a study of major weight loss in free-living 428 
human subjects, and it was beyond the scope of the current study. Finally, our results were 429 
derived only in Caucasian women.   430 
In conclusion, our findings imply that habitually higher fasting GLP-1 concentrations and 431 
lower reduction in GLP-1 during diet-induced weight loss form part of a favourable 432 
biological profile for long-term weight loss maintenance. However, difficulties in self-433 
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regulating eating behaviour whilst experiencing stress and negative emotions may 434 
contribute to weight regain.  435 
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Figure 3: Individual plasma concentrations of a) Leptin, b) GLP-1, c) Ghrelin, d) PYY and e) GDF-15 measured before and after weight loss. 
Black circles indicate baseline values (•) and grey circles indicate post weight loss values (•) for each participant. Black dashed lines indicate 
mean value at baseline (- - -) and grey dashed lines indicates mean value after weight loss (- - -) 
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Figure 4: Associations between weight regain (kg) from 6 to 24 months and a) GLP-1 measured at baseline; b) GLP-1 measured after weight loss, and c) 
change in GLP-1 from baseline to maximal weight loss 
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Table 1: Weight and body composition, energy expenditure, and fasting plasma hormone 
and metabolite concentrations before and after weight loss. Values are means ± SD (n=15†) 
 
Participant characteristics Baseline 6 months P value 
Weight (kg) 103.0 ± 15.5 89.2 ± 15.2 <0.001 
BMI (kg/m2) 
Total adipose tissue mass (kg) 
39.4 ± 4.3 
54.6 ± 12.7 
34.1 ± 4.8 
43.1 ± 13.2 
<0.001 
<0.001 
Skeletal muscle mass (kg) 28.8 ± 4.0 28.4 ± 3.8 0.121 
RMR (kcal/day) 1788 ± 349 1497 ± 225 <0.001 
Measured–predicted RMR (kcal/day) 
Leptin (ng/mL) 
n/a 
64.0 ± 12.2 
-150 ± 162 
39.5 ± 21.6 
0.003 
<0.001 
Total Ghrelin (pg/mL) 573.8 ± 232.0 814.5 ± 337.0 0.001 
Total GLP-1 (pmol/L) 45.1 ± 21.9 32.1 ± 12.4 0.015 
PYY (pg/mL) 
GDF-15 (pg/mL) 
Insulin (µU/mL) 
Glucose (mmol/L) 
70.7 ± 34.5 
573.7 ± 235.4 
 
12.9 ± 6.6 
 
6.4 ± 1.7 
88.1 ± 26.1 
568.4 ± 184.2 
 
10.5 ± 6.1 
 
5.8 ± 1.4 
0.157 
0.861 
 
0.110 
 
0.861 
 
BMI, body mass index; eFFM, estimated fat free mass; eFM, estimated fat mass; RMR, resting metabolic rate  
†Biochemical data (leptin, ghrelin, GLP-1, PYY, GDF-15 insulin and glucose) is based on 14 participants 
 
 
Table 2: Examples of verbatim quotes relevant to hunger, stress and coping during weight loss maintenance  
      Perspective Verbatim quotes 
 
 
Hunger / appetite  
 
“I actually feel as if I eat more now than I did before, but obviously it’s healthy choices […] whereas before I always felt hungry...” 
 (P-8, 24-months) 
“…I don’t finish dinners as I used to. I used to finish my whole plate […] I assume that my stomach has got smaller, it can only take so 
much food...”(P-15, 24-months) 
“I am conscious of feeling really full, much much quicker now.” (P-12, 14 months) 
 “…It was really clear to me that it [overeating] actually wasn’t about hunger […] I think that was one thing I realised, that my issues 
aren’t actually to do with hunger.” (P-11, 15-months) 
 “I don’t really eat because I am hungry, I know that I am eating for something else.” (P-10, 24-months) 
 
Stress and coping  “When I’m stressed and tired I lose the focus. I don’t want to be restricting myself […], I don’t want to punish myself any further, I want 
to enjoy something nice and think oh well I have had a shit day, I deserve something good...” (P-10, 24-months) 
“…If it’s only maybe one kind of stress, kind of work-related or home related I am fine [...] but if it’s more than one area of my life I find 
it difficult. (P-4, 24-months) 
 “…I think I have got that much else going on in life to think about, food as an added thing, it’s just too much for me.” (P-13, 24 months) 
“…I had my PDR [personal development review] recently and my colleague was saying to me, you managed to survive a stressful time at 
work without chocolate, and I said could I put it on my PDR, like my goal!” (P-4, 24-months) 
“…the way I would have been normally would have been oh poor me I am going through all this stress […], that would have been a 
trigger to say, do you know what, I don’t need to cook, I am just going to get a takeaway, […] and just open a bottle of wine. I have not 
done any of that at all.” (P-8, 24-months) 
 “…you think it’s going to be a stress reliever, but in actual fact after I’ve done it I think to myself oh why did you do that, why did you do 
that, you have blown it […] and then you get mad with yourself and you beat yourself up…” (P-12, 12-months) 
“I think my mood did really dip, and I think I was probably drinking and eating because I was probably feeling a wee bit depressed.” (P-
6, 16-months) 
“I get low, I do because that’s life, you have your up and down days. It might be a crap day at work, and you do get low, and yeah I 
probably would on a low day turn to chocolate…”(P-13, 24-months) 
 
Weight loss and maintenance data of each participant in the qualitative study (abbreviated as ‘P’ and identified by participant number): 
 
P-4, Start weight: 110kg   Lowest weight: 81.7kg   24-month weight: 91.3kg, 18.5% body weight loss 
P-6, Start weight: 118kg   Lowest weight: 75kg   24-month weight: 85.3kg, 28.1% body weight loss 
P-7, Start weight: 118.9kg   Lowest weight: 104.2kg   24-month weight: 114.3kg, 3.9% body weight loss 
P-8, Start weight: 95.1kg  Lowest weight: 82.2kg,   24-month weight: 86.2kg, 9.4% body weight loss 
P-9, Start weight: 105.9kg   Lowest weight: 96.2kg   24-month weight: 106.5kg, 0.6% body weight gain 
P-10, Start weight: 97.1kg   Lowest weight: 85.7kg,   24-month weight: 90.2 kg, 7.1% body weight loss 
P-11, Start weight: 132.7kg Lowest weight: 118.2kg   24-month weight: 133.9kg, 1.2% body weight gain  
P-12, Start weight: 114.1kg  Lowest weight: 94.5kg   24-month weight: 102.2kg, 10.4% body weight loss 
P-13, Start weight: 84.1kg   Lowest weight: 73.9kg,   24-month weight: 80.5kg, 4.3% body weight loss 
P-14, Start weight: 118kg  Lowest weight: 100.2kg  24-month weight: 109.1 kg, 7.5% body weight loss 
P-15, Start weight: 88.9kg   Lowest weight: 71.9kg   24-month weight: 81kg, 8.9% body weight loss 
 
 
